The global point of care diagnostics market is expanding as healthcare providers increasingly adopt rapid testing solutions that deliver diagnostic results close to patients. Point of care (POC) diagnostics allow tests to be performed in clinics, hospitals, physician offices, pharmacies, and home-care settings, reducing dependence on centralized laboratories. These solutions support faster clinical decisions, early disease detection, and timely treatment. Growing demand for decentralized healthcare, rising prevalence of infectious and chronic diseases, an aging population, and advancements in portable diagnostic technologies are creating new opportunities for market participants.

Download a free sample copy of the Point Of Care Diagnostics market report to understand detailed coverage and inclusions in the final report

Market Size and Growth Projections

The global point of care diagnostics market was valued at USD 21.7 billion in 2025. It is estimated to reach USD 22.6 billion in 2026 and is projected to reach USD 29.9 billion by 2033, registering a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033. North America dominated the market in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period.

Key Market Statistics

Key market indicators include:

• Market Size (2025): USD 21.7 billion
• Market Estimate (2026): USD 22.6 billion
• Projected Market Value (2033): USD 29.9 billion
• Market CAGR:1% from 2026 to 2033
• Dominant Region: North America, with 37.1% revenue share in 2025
• Leading Product Segment: Infectious disease testing, with 30.5% revenue share in 2025
• Leading End-Use Segment: Clinics, which accounted for the largest revenue share in 2025
• Fastest-Growing Region: Asia Pacific
• Fastest-Growing End Use: Home-based testing

Key Trends and Market Drivers

The increasing prevalence of infectious diseases is a major factor supporting demand for point of care diagnostics. Rapid testing solutions help healthcare professionals identify infections and make treatment decisions without waiting for conventional laboratory results. Tests for influenza, HIV, hepatitis, tuberculosis, respiratory infections, and other conditions are increasingly used in decentralized healthcare settings.

The growing burden of chronic diseases is another important driver. Diabetes, cardiovascular disorders, and cancer require regular monitoring and timely diagnosis. POC glucose testing, HbA1c testing, cardiac marker analysis, and other rapid diagnostic solutions help healthcare providers and patients monitor health conditions more efficiently.

The aging population is also contributing to market growth. Older adults often require frequent diagnostic testing and ongoing disease management. Portable testing devices and home-based solutions can improve access to healthcare while reducing unnecessary visits to hospitals and laboratories.

Technological advancements are further supporting adoption. Miniaturized analyzers, molecular testing platforms, biosensors, and digital connectivity are improving the speed, portability, and usability of diagnostic devices. However, maintaining test accuracy, meeting regulatory requirements, and managing device costs remain important challenges.

Go Deeper! Ask Prism AI

about the Global Point Of Care Diagnostics Market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Key Market Segments

By product, infectious disease testing dominated the market, accounting for 30.5% of global revenue in 2025. Demand is supported by the need for rapid identification of infectious conditions and the expansion of decentralized testing services. Other important product categories include glucose testing, HbA1c testing, coagulation testing, fertility and pregnancy testing, cardiac markers, thyroid-stimulating hormone testing, hematology, lipid testing, cancer markers, blood gas and electrolyte testing, and urinalysis.

The cancer segment is expected to register the fastest growth during the forecast period. Increasing demand for early cancer detection, biomarker testing, and companion diagnostics is encouraging the development of advanced point of care solutions.

By end use, clinics accounted for the largest revenue share in 2025. Physician offices, urgent care centers, and pharmacy-based clinics use POC tests to support faster diagnosis and treatment decisions. The home segment is expected to grow at the fastest rate as patients increasingly adopt convenient testing solutions for chronic disease monitoring and routine healthcare management. Hospitals, assisted living healthcare facilities, and laboratories also represent important end-use categories.

Regional Market Performance

North America dominated the point of care diagnostics market, accounting for 37.1% of global revenue in 2025. The region benefits from established healthcare infrastructure, high healthcare expenditure, an aging population, and the presence of major diagnostic technology companies. Growing adoption of rapid testing devices and connected healthcare solutions is supporting regional demand.

Europe represents an important market due to increasing chronic disease prevalence, established healthcare systems, and demand for rapid diagnostic services. Countries such as Germany, the UK, and France are adopting advanced testing platforms across hospitals, clinics, and other healthcare facilities.

Asia Pacific is expected to register the fastest regional growth, with a projected CAGR of 6.29% during the forecast period. Rising healthcare investments, growing awareness of early disease detection, and increasing prevalence of diabetes, cancer, and infectious diseases are supporting adoption. China, India, Japan, and South Korea represent important markets as healthcare infrastructure and access to decentralized testing continue to expand.

Latin America is witnessing growing demand for affordable diagnostic solutions, particularly for infectious disease screening and decentralized testing. In the Middle East and Africa, investments in healthcare infrastructure, expanding clinic networks, and government initiatives to improve diagnostic access are creating opportunities for POC device manufacturers.

Looking for more specific insights? Customize this report to suite your business needs

Top Industry Players

The competitive landscape includes established medical technology companies, diagnostic equipment manufacturers, and specialized testing solution providers. Major industry participants include:

• Hoffmann-La Roche Ltd.
• Abbott
• Danaher Corporation
• Becton, Dickinson and Company (BD)
• bioMérieux SA
• Siemens Healthineers AG
• QIAGEN N.V.
• Werfen
• Nova Biomedical
• QuidelOrtho Corporation
• Trinity Biotech plc
• OraSure Technologies, Inc.
• EKF Diagnostics Holdings plc
• Sekisui Diagnostics

Competition is focused on improving test accuracy, reducing turnaround times, expanding test menus, and developing portable and user-friendly diagnostic platforms. Companies are also investing in molecular diagnostics, digital connectivity, product innovation, and strategic partnerships to strengthen their market presence.

Overall, the point of care diagnostics market is moving toward faster, more accessible, and decentralized testing solutions. Increasing demand for early disease detection, chronic disease monitoring, home-based testing, and advanced diagnostic technologies is expected to support market growth through 2033.

U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.